Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 5 January 2026

D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026

D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026

D-Wave Quantum shares jumped nearly 10% to around $30.91 Monday amid a surge in large call-option trades flagged by Benzinga. The rally comes ahead of D-Wave’s CES Foundry appearance Jan. 7–8, where investors are watching for new customer or partnership announcements. QBTS traded between $27.79 and $31.20, with about 31 million shares changing hands by mid-afternoon. Other U.S.-listed quantum stocks also rose.
5 January 2026
·····
Gulfport Energy stock (GPOR) slides nearly 9% on Wolfe downgrade as gas prices fall

Gulfport Energy stock (GPOR) slides nearly 9% on Wolfe downgrade as gas prices fall

Gulfport Energy shares fell 8.7% to $188.26 after Wolfe Research downgraded the stock, citing weaker natural gas prices and a lower long-term gas forecast. U.S. natural gas dropped 3.5% to $3.49 per MMBtu. Other gas producers also declined. Investors await the Jan. 8 U.S. storage report and Gulfport’s next earnings date, estimated for late February.
5 January 2026
···
SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime shares fell nearly 9% to $336.50 Monday afternoon, erasing earlier gains and much of their start-of-year advance. The drop came after the stock surpassed the average analyst target of $355, drawing valuation scrutiny. The move contrasted with a 1.7% gain in the PHLX Semiconductor Index as chip stocks broadly rallied. Investors are watching for SiTime’s next earnings update.
5 January 2026
····
Structure Therapeutics stock slides nearly 8% as Novo’s Wegovy pill debut jolts oral obesity-drug bets

Structure Therapeutics stock slides nearly 8% as Novo’s Wegovy pill debut jolts oral obesity-drug bets

Structure Therapeutics shares fell 7.7% to $62.86 after Novo Nordisk began U.S. sales of its Wegovy pill at $149 a month for self-paying patients. Structure’s stock had reached $72.02 earlier in the session before retreating. Investors await updates on its Phase 3 plans and next earnings report, expected Feb. 26.
5 January 2026
·····
Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

Astera Labs shares dropped 8.4% to $164.50 Monday after a regulatory filing showed general counsel Philip Mazzara plans to sell 30,000 shares worth about $5 million. The stock reversed from a session high near $185, trading over 5 million shares by early afternoon. Semiconductor ETFs rose, but Astera lagged. Investors are watching for further insider filings and signals from hyperscale customers.
5 January 2026
·
Bitcoin price jumps near $94,000 as Coinbase stock surges on Goldman upgrade, Strategy buys more BTC

Bitcoin price jumps near $94,000 as Coinbase stock surges on Goldman upgrade, Strategy buys more BTC

Bitcoin climbed 3.3% to $94,161 in New York afternoon trading Monday, with Coinbase jumping 7.6% after a Goldman Sachs upgrade. Strategy disclosed buying 1,283 bitcoin for $116 million in an SEC filing. Crypto stocks and tokens tracked the move higher as traders watched fallout from the U.S. capture of Venezuela’s president and awaited U.S. jobs data due Friday.
5 January 2026
······
Silver price stock SLV climbs nearly 6% as Venezuela strikes lift safe-haven demand

Silver price stock SLV climbs nearly 6% as Venezuela strikes lift safe-haven demand

Shares of iShares Silver Trust (SLV) jumped 5.7% to $69.49 and spot silver rose 6% to $76.99 an ounce Monday after U.S. strikes in Venezuela spurred safe-haven demand. Traders are watching upcoming U.S. jobs and inflation data for signals on interest rates. Silver hit an all-time high of $83.62 recently. The U.S. employment report is due Friday.
5 January 2026
···
Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

Arrowhead Pharmaceuticals shares fell 6.9% to $63.11 Monday after Health Canada approved Redemplo, its triglyceride-lowering drug for familial chylomicronemia syndrome. The stock dropped despite the clearance, tracking weakness across biotech stocks. Investors now await Arrowhead’s obesity data webinar on Jan. 6 and its J.P. Morgan conference presentation Jan. 12.
5 January 2026
···
Chevron stock jumps on Trump Venezuela oil move; traders eye sanctions and Jan. 30 earnings

Chevron stock jumps on Trump Venezuela oil move; traders eye sanctions and Jan. 30 earnings

Chevron shares jumped 5.7% to $164.78 after U.S. forces captured Venezuelan President Nicolás Maduro, fueling bets on renewed access to Venezuela’s oil. Chevron, the only U.S. major still operating there under a waiver, exported up to 150,000 barrels per day to the U.S. Gulf Coast late last year. ConocoPhillips and Exxon Mobil also gained. Brent crude rose 1.58% to $61.71 a barrel.
5 January 2026
······
1 … 472 473 474 475 476 … 1,170

Stock Market Today

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

7 February 2026
Walmart shares climbed 3.34% to $131.18 Friday, pushing its market value to about $1.05 trillion as the Dow closed above 50,000 for the first time. Retail stocks mostly gained, with Target up 4.24% and Costco up 1.20%, while Amazon dropped 5.55%. Investors await Walmart’s fiscal Q4 results on Feb. 19 and key U.S. economic data next week.
Go toTop